Tradestie Institutional Equity Comparison Engine

CYAB vs SNYR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SNYR Overall Edge

SNYR Captures Institutional Edge (3โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Synergy CHC Corp. Common Stock (SNYR) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, CYAB trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus SNYR at 0.6x Forward P/E and -10.3% operating margin (-32.8% YoY). In options structure, CYAB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SNYR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner SNYR
CYAB N/M vs SNYR 0.6x Fwd P/E
Growth & Margin Winner SNYR
Op Margin N/A vs -10.3% ยท YoY N/A vs -32.8%
Momentum & Technical Winner SNYR
1Y -98.3% vs -96.2% ยท 52W Pos 0% vs 1%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
CYAB US Equity
CYAB
Institutional Equity
$0.06
-3.39% 1D
Market Cap N/A
1M Return -56.18%
1Y Return -98.3%
Forward P/E N/M
Unified AI Score
48.4 / 100 HOLD
Tech 43.0 Fund 52.0 Flow 50.0 Mom 88.9
SNYR NASDAQ
Synergy CHC Corp. Common Stock
Medicinal Chemicals & Botanical Products
$0.09
-67.02% 1D
Market Cap $4.1M
1M Return -16.28%
1Y Return -96.15%
Forward P/E 0.6x
Unified AI Score
48.9 / 100 HOLD
Tech 55.0 Fund 39.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CYAB -98.3% SNYR -96.15% Spread: +0.65 pp (CYAB Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CYAB TTM Op. Margin: N/A SNYR TTM Op. Margin: -10.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CYAB vs SNYR. Trailing 12-month operating profitability (CYAB N/A vs SNYR -10.3%) and valuation multiples (CYAB N/M vs SNYR 0.6x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CYAB (1) vs SNYR (9)
Institutional Metric CYAB SNYR Criterion Row Winner
Market Capitalization Scale N/A $4.1M Larger Scale SNYR
Trailing P/E Ratio Valuation N/M 0.6x Lower Multiple SNYR
Forward P/E Ratio Valuation N/M 0.6x Lower Multiple SNYR
Revenue Growth (YoY) Growth N/A -32.8% Higher Growth SNYR
Operating Margin (TTM) Profitability N/A -10.3% Higher Margin SNYR
Net Profit Margin Profitability N/A -57.0% Higher Margin SNYR
Return on Equity (ROE) Capital Efficiency N/A -361.1% Higher ROE SNYR
52-Week Range Position Momentum 0% ($0โ€“$6) 1% ($0โ€“$3) Stronger Trend SNYR
Beta / 30D Volatility Risk Regime 0.45ฮฒ ยท 246% Vol -0.86ฮฒ ยท 868% Vol Lower Realized Risk CYAB
Unified Institutional Score Composite Signal 48.4 / 100 (HOLD) 48.9 / 100 (HOLD) Higher Composite SNYR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CYAB vs SNYR Buy Guide
CYAB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CYAB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SNYR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SNYR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CYAB nor SNYR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.